NASDAQ:PETSPetmed Express Stock Price, Forecast & News

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PETS stock has increased by 36.4% and is now trading at $35.40. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Petmed Express.

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, July 27th 2020. View our earnings forecast for Petmed Express.

Petmed Express Inc (NASDAQ:PETS) released its quarterly earnings results on Monday, May, 4th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.29 by $0.06. The company had revenue of $74.30 million for the quarter, compared to the consensus estimate of $66.24 million. Petmed Express had a net margin of 9.10% and a return on equity of 20.40%. The company's revenue for the quarter was up 15.0% on a year-over-year basis. During the same quarter last year, the business earned $0.32 earnings per share. View Petmed Express' earnings history.

Petmed Express announced a quarterly dividend on Monday, May 4th. Shareholders of record on Friday, May 15th will be given a dividend of $0.28 per share on Friday, May 22nd. This represents a $1.12 dividend on an annualized basis and a yield of 3.16%. The ex-dividend date of this dividend is Thursday, May 14th. This is a positive change from Petmed Express's previous quarterly dividend of $0.27. View Petmed Express' dividend history.

2 brokers have issued 12-month price targets for Petmed Express' shares. Their forecasts range from $20.00 to $31.00. On average, they anticipate Petmed Express' share price to reach $25.50 in the next twelve months. This suggests that the stock has a possible downside of 28.0%. View analysts' price targets for Petmed Express.

News articles about PETS stock have been trending negative recently, InfoTrie reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Petmed Express earned a news sentiment score of -2.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutPetmed Express.

Petmed Express saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 4,200,000 shares, a decline of 10.1% from the April 30th total of 4,670,000 shares. Based on an average trading volume of 623,300 shares, the days-to-cover ratio is currently 6.7 days. Approximately 21.6% of the shares of the company are short sold. View Petmed Express' Current Options Chain.

Some companies that are related to Petmed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), Tripadvisor (TRIP), Shutterfly (SFLY), 1-800-Flowers.Com (FLWS), Groupon (GRPN), Overstock.com (OSTK) and U.S. Auto Parts Network (PRTS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), AT&T (T), NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Cisco Systems (CSCO), Netflix (NFLX), Verizon Communications (VZ), Micron Technology (MU) and Advanced Micro Devices (AMD).

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Petmed Express' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.26%), State Street Corp (4.13%), Bank of New York Mellon Corp (1.84%), Morgan Stanley (1.62%), Personal Capital Advisors Corp (1.57%) and Geode Capital Management LLC (1.53%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer. View institutional ownership trends for Petmed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Citigroup Inc., Rothschild Investment Corp IL, BlackRock Inc., Polaris Capital Management LLC, Chicago Equity Partners LLC, North Star Investment Management Corp., Voloridge Investment Management LLC, and Rhumbline Advisers. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag. View insider buying and selling activity for Petmed Express.

PETS stock was bought by a variety of institutional investors in the last quarter, including Maverick Capital Ltd., Maverick Capital Ltd., Balyasny Asset Management LLC, Morgan Stanley, Hancock Whitney Corp, State Street Corp, Advisor Group Holdings Inc., and Robeco Institutional Asset Management B.V.. View insider buying and selling activity for Petmed Express.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETS stock can currently be purchased for approximately $35.40.

Petmed Express has a market capitalization of $713.88 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

The official website for Petmed Express is www.1800petmeds.com.

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.